De-implementation of Low Value Castration for Men With Prostate Cancer

Completed · Not applicable

Conditions studied: Cancer of Prostate

In brief

This study will use a theory-based, mixed methods approach to identify, tailor and pilot two different de-implementation strategies that vary widely in delivery, impact, and expected results for reducing low value androgen deprivation therapy (ADT) use in preparation for a randomized comparative effectiveness trial comparing two tailored deimplementation strategies to reduce chemical castration as localized prostate cancer treatment and treatment for non-metastatic biochemical recurrence with low PSA levels.

Key facts

Study ID

NCT03579680

Run by

University of Michigan

People needed

60

Starts

2018-08-22

Expected to finish

2023-04-06

Last updated by the study team

2024-09-05

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Any provider at participating sites who prescribes ADT for prostate cancer patients

You may not qualify if…

• Providers opting out of study

Where it is running

• VA Ann Arbor Healthcare System — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.